The global compression therapy market size was estimated at USD 4.43 billion in 2025 and is projected to reach USD 5.88 billion by 2033, growing at a CAGR of 3.54% from 2026 to 2033, driven by the rising prevalence of venous and lymphatic disorders such as Deep Vein Thrombosis (DVT), varicose veins, lymphedema, and chronic venous insufficiency. Compression therapy, which applies controlled pressure to improve blood circulation and reduce swelling, has become an essential solution for both prevention and treatment of these conditions.
Growth is further fueled by the increasing burden of chronic diseases such as obesity, diabetes, and cardiovascular conditions, along with a rapidly aging global population that is more susceptible to circulatory disorders. In addition, the rising number of surgical procedures and sports-related injuries is boosting demand for compression therapy in post-operative care and rehabilitation.
The rising prevalence of Deep Vein Thrombosis (DVT) is significantly growing the compression therapy market, as the condition requires effective prevention and management strategies to reduce complications. DVT, which involves the formation of blood clots in deep veins primarily in the legs, is becoming more common due to factors such as sedentary lifestyles, increasing obesity rates, an aging population, and a higher number of surgical procedures. Compression therapy, including stockings and pneumatic devices, is widely recommended to improve blood circulation, prevent clot formation, and reduce the risk of post-thrombotic complications.
Conditions such as chronic venous insufficiency and venous ulcers impact many people worldwide, with factors such as aging populations, inactive lifestyles, and obesity playing a major role. Compression therapy for venous ulcers is highly effective; therefore, the rising prevalence of venous ulcers will drive market growth in the near future. Moreover, compression therapy for varicose veins is a highly effective treatment compared to other options. For instance, data from the Society for Vascular Surgery indicate that as many as 40 million Americans have varicose veins. Moreover, according to an article published by NCBI, around 150,000 new cases of chronic venous insufficiency are diagnosed each year, with approximately USD 500 million spent on the care of these patients.
Compression therapy works by applying controlled pressure to the affected limbs, helping ease symptoms, enhance blood flow, reduce swelling, and aid healing, while preventing complications. Thus, the growing awareness of compression therapy's effectiveness in managing chronic venous conditions is expected to drive market growth.
The growing number of orthopedic procedures is driving an increased need for compression therapy as part of postoperative care and rehabilitation protocols. Orthopedic surgeries, including joint replacements (such as knee or hip replacements), fracture repairs, ligament reconstructions, and arthroscopic surgeries, are becoming more common due to factors such as an aging population, sports-related injuries, and advancements in surgical techniques. For instance, according to data from the American College of Rheumatology, the number of knee and hip replacements performed annually in the U.S. is on the rise due to the aging population, with approximately 790,000 knee replacements and 544,000 hip replacements performed each year. According to data published by the Australian Orthopedic Association National Joint Replacement Registry (AOANJRR) in 2024, more than 2.1 million orthopedic procedures were performed in Australia.
After an orthopedic procedure, patients commonly experience swelling, inflammation, and reduced mobility in the operated limbs. Compression therapy plays a vital role in managing these postoperative symptoms and in providing recovery by improving blood circulation, reducing swelling, and supporting the surgical site.
The increasing cases of obesity have led to an increase in the adoption of compression therapy as a crucial device in managing health-related concerns. Obesity, characterized by excessive body fat accumulation, not only increases the risk of chronic disorders such as CVD, diabetes, & hypertension but also contributes to venous insufficiency and associated disorders. For instance, an article published in the International Journal of Medical Science and Clinical Invention suggests that obesity increases the risk of venous insufficiency and associated complications by more than sixfold. As per the World Obesity Federation, in 2024, more than one billion people worldwide were living with obesity, which is about one in eight people. This includes nearly 880 million adults, and 159 million children and adolescents aged 5-19. The World Obesity Federation’s 2025 Atlas, published on World Obesity Day (4 March), projects that the total number of adults living with obesity will increase by more than 115% between 2010 and 2030, from 524 million to 1.13 billion.
This product will be delivered within 1-3 business days.
Growth is further fueled by the increasing burden of chronic diseases such as obesity, diabetes, and cardiovascular conditions, along with a rapidly aging global population that is more susceptible to circulatory disorders. In addition, the rising number of surgical procedures and sports-related injuries is boosting demand for compression therapy in post-operative care and rehabilitation.
The rising prevalence of Deep Vein Thrombosis (DVT) is significantly growing the compression therapy market, as the condition requires effective prevention and management strategies to reduce complications. DVT, which involves the formation of blood clots in deep veins primarily in the legs, is becoming more common due to factors such as sedentary lifestyles, increasing obesity rates, an aging population, and a higher number of surgical procedures. Compression therapy, including stockings and pneumatic devices, is widely recommended to improve blood circulation, prevent clot formation, and reduce the risk of post-thrombotic complications.
- According to the Centers for Disease Control and Prevention (CDC) data from 2025, up to 900,000 people in the U.S. are affected by venous thromboembolism (VTE) each year, highlighting the significant burden of this condition on the healthcare system.
Conditions such as chronic venous insufficiency and venous ulcers impact many people worldwide, with factors such as aging populations, inactive lifestyles, and obesity playing a major role. Compression therapy for venous ulcers is highly effective; therefore, the rising prevalence of venous ulcers will drive market growth in the near future. Moreover, compression therapy for varicose veins is a highly effective treatment compared to other options. For instance, data from the Society for Vascular Surgery indicate that as many as 40 million Americans have varicose veins. Moreover, according to an article published by NCBI, around 150,000 new cases of chronic venous insufficiency are diagnosed each year, with approximately USD 500 million spent on the care of these patients.
Compression therapy works by applying controlled pressure to the affected limbs, helping ease symptoms, enhance blood flow, reduce swelling, and aid healing, while preventing complications. Thus, the growing awareness of compression therapy's effectiveness in managing chronic venous conditions is expected to drive market growth.
The growing number of orthopedic procedures is driving an increased need for compression therapy as part of postoperative care and rehabilitation protocols. Orthopedic surgeries, including joint replacements (such as knee or hip replacements), fracture repairs, ligament reconstructions, and arthroscopic surgeries, are becoming more common due to factors such as an aging population, sports-related injuries, and advancements in surgical techniques. For instance, according to data from the American College of Rheumatology, the number of knee and hip replacements performed annually in the U.S. is on the rise due to the aging population, with approximately 790,000 knee replacements and 544,000 hip replacements performed each year. According to data published by the Australian Orthopedic Association National Joint Replacement Registry (AOANJRR) in 2024, more than 2.1 million orthopedic procedures were performed in Australia.
After an orthopedic procedure, patients commonly experience swelling, inflammation, and reduced mobility in the operated limbs. Compression therapy plays a vital role in managing these postoperative symptoms and in providing recovery by improving blood circulation, reducing swelling, and supporting the surgical site.
The increasing cases of obesity have led to an increase in the adoption of compression therapy as a crucial device in managing health-related concerns. Obesity, characterized by excessive body fat accumulation, not only increases the risk of chronic disorders such as CVD, diabetes, & hypertension but also contributes to venous insufficiency and associated disorders. For instance, an article published in the International Journal of Medical Science and Clinical Invention suggests that obesity increases the risk of venous insufficiency and associated complications by more than sixfold. As per the World Obesity Federation, in 2024, more than one billion people worldwide were living with obesity, which is about one in eight people. This includes nearly 880 million adults, and 159 million children and adolescents aged 5-19. The World Obesity Federation’s 2025 Atlas, published on World Obesity Day (4 March), projects that the total number of adults living with obesity will increase by more than 115% between 2010 and 2030, from 524 million to 1.13 billion.
Global Compression Therapy Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the compression therapy market report based on technology, end use, distribution channel, and region.Technology Outlook (Revenue, USD Million, 2021-2033)
- Static Compression Therapy
- Compression Bandages
- Compression Stockings
- Compression Tape
- Others Compression Garments
- Dynamic Compression Therapy
- Compression Pumps
- Compression Sleeves
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Specialty Clinics
- Home Healthcare
- Physician’s Office
- Nursing Homes
- Others
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Institutional Sales
- Retail Sales
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Compression Therapy Market Variables, Trends, & Scope
Chapter 4. Compression Therapy Market: Technology Estimates & Trend Analysis
Chapter 5. Compression Therapy Market: End Use Estimates & Trend Analysis
Chapter 6. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis
Chapter 7. Compression Therapy Market: Regional Estimates & Trend Analysis by Technology, by End Use, by Distribution Channel
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Essity Aktiebolag (publ).
- Cardinal Health
- Julius Zorn GmbH
- Hartmann AG
- Medi GmbH & Co.
- SIGVARIS
- ArjoHuntleigh
- 3M (Solventum)
- Spectrum Healthcare
- Bio Compression Systems, Inc.
- Stryker
- Gottfried Medical
- Tactile Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 300 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 4.43 Billion |
| Forecasted Market Value ( USD | $ 5.88 Billion |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
